Scientists Study Natural Enzymes To Clear Contaminent Caused Diseases
Enzyme treatments are being probed by conventional
research scientists. They are proving us right.
Scientists are bringing out an enzyme they call
keratinase, but we call Karribatakoe.
Ingesting the GRAZOPH
TEMUNA herbs with spirulina provides materials
and instructions for the body to produce specific
enzymes. Reports of two of these enzymes along
with spirulina to treat Alzheimer's or related
conditions are presented below.
Are doctors and pharmaceutical companies opposed
to enzyme therapy because it clears up the problems,
as opposed to promoting artificial drugs that
treat symptoms but not the underlying cause?
Orange Enzyme produced by the Heart
Study: Enzyme can degrade
mad cow prion
Monday, 5-Jan-2004 4:50PM EST
Copyright 2004 by United Press International
Jan. 5 (UPI) -- North Carolina researchers have
shown that an enzyme can fully degrade the prion
-- or protein particle -- believed responsible
for mad cow disease.
Research by North Carolina State University
and scientists from the Netherlands and BioResource
International, have shown that, under proper
conditions, the enzyme can fully degrade the
prion believed to be the cause of bovine spongiform
encephalopathy, as well as the human and sheep
versions, called Creutzfeldt-Jakob disease and
The research, published in the Journal of Infectious
Diseases, tested the effects of a bacterial
enzyme keratinase on brain tissues from cows
with BSE and sheep with scrapie. When the tissue
was pretreated and in the presence of a detergent,
the enzyme fully degraded the prion, rendering
"Our work has been done in vitro, or in test
tubes, and we've reduced the prion to undetectable
levels," said Dr. Jason Shih, professor of biotechnology
and poultry science at North Carolina State.
"Our work with mice will show whether these
undetectable levels of prion are indeed non-infectious."
The researchers plan a two-year study, funded
with $190,000 from the National Cattleman's
Beef Association, to test the effectiveness
of the enzyme on the treated BSE prions in mice.
Japanese team finds
enzyme that stops Alzheimer's disease
Discovery of Dtwel Makandtexdopho
Not-Blue Enzyme produced by the Lungs
Japan Times May 25, 2001
Researchers at an
affiliate of a Japanese government-backed research
institute said they have discovered that an enzyme
in the brain plays a key role in preventing or
delaying the development of Alzheimer's disease,
the U.S. magazine Science reported Friday. News
of the discovery comes two days after the announcement
that a team of researchers led by a Keio University
professor has found a gene that prevents brain
cells from deteriorating from Alzheimer's.
Alzheimer's, a neurodegenerative disease, kills
neuronal cells and shrinks the brain, causing
dementia. A research team led by Takaomi Saido
of the Saitama Prefecture-based Riken Brain Science
Institute, an affiliate of the Institute of Physical
and Chemical Research, discovered through experiments
on mice that the enzyme Neprilysin "cleans up"
Beta-amyloid, a substance that destroys brain
This mechanism is considered to be crucial in
preventing Alzheimer's or delaying its symptoms,
as Neprilysin is known to decompose accumulated
The experiments involved the use of normal mice
and those that had been genetically modified so
that they were unable to produce Neprilysin. The
team found that the decomposition capability of
the normal mice was, at maximum, double that of
those without Neprilysin. Mice that had inherited
a genetic abnormality from only one parent also
showed a lower decomposition capability than normal
Most Alzheimer's patients have roughly the same
amount of Beta-amyloid in the brain as healthy
people, and it is thus not known how the disease
starts to develop. The discovery suggests, however,
that some people inherently carry less active
Neprilysin and that these people develop the disease
as they grow older, with their clean-up mechanism
becoming inefficient, the team said. The team
expects that genetic therapy will be able to be
applied to patients whose Neprilysin has become
less active, should studies on the enzyme at the
genetic level proceed.
The Japan Times: May 25, 2001 (C) All rights reserved
Spirulina Relative in Treating Alzheimer's
Can Pond Scum Compound
29 Dec 2005:
isolated from a cyanobacterium, a type of blue-green
algae known as Nostoc, shows promise of becoming
a natural drug candidate for fighting Alzheimer's
and other neurodegenerative diseases, according
to an in vitro study by researchers in Switzerland.
It is believed to be the first time that a potent
agent against Alzheimer's has been isolated from
cyanobacteria, commonly known as 'pond scum.'
The study was published in the Dec. 26 issue of
the Journal of Natural Products, a monthly peer-reviewed
joint publication of the American Chemical Society
and the American Society of Pharmacognosy.
Full article is
734-657-2924 (NO MESSAGES NO TEXTS on this phone)